Literature DB >> 4338426

Increased prothrombin time and metabolic changes with high serum aluminum levels following long-term exposure to Bayer-process alumina.

D Waldron-Edward, P Chan, S C Skoryna.   

Abstract

Serum aluminum levels twice to three times those in controls were found in 30 of 36 workers in a factory in an atmosphere of alumina dust. Inorganic phosphate and total alkaline phosphatase levels were within normal range, with no clinical evidence of phosphate depletion syndrome. Serum intestinal alkaline phosphatase, acid phosphatase and adenosine triphosphate levels were significantly reduced in the group with high levels of aluminum. The finding that the mean prothrombin time was significantly prolonged is of particular interest with respect to beneficial antithrombogenic effect.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4338426      PMCID: PMC1931331     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  OSTEOMALACIA AND DEBILITY RESULTING FROM PHOSPHORUS DEPLETION.

Authors:  M LOTZ; R NEY; F C BARTTER
Journal:  Trans Assoc Am Physicians       Date:  1964

2.  Trace elements in human tissue. II. Adult subjects from the United States.

Authors:  I H TIPTON; M J COOK
Journal:  Health Phys       Date:  1963-02       Impact factor: 1.316

3.  Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine.

Authors:  P R KIND; E J KING
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

4.  The biochemistry of aluminium: Excretion and absorption of aluminium in the pig.

Authors:  K Mackenzie
Journal:  Biochem J       Date:  1930       Impact factor: 3.857

5.  Variability in the metal content of human organs.

Authors:  H M PERRY; I H TIPTON; H A SCHROEDER; M J COOK
Journal:  J Lab Clin Med       Date:  1962-08

6.  The effect of beryllium on certain enzymes.

Authors:  F W KLEMPERER
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

7.  Hyperaluminaemia from aluminum resins in renal failure.

Authors:  G M Berlyne; J Ben-Ari; D Pest; J Weinberger; M Stern; R Levine; G R Gilmore
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

8.  "Tertiary" hyperparathyroidism induced by osteomalacia resulting from phosphorus depletion.

Authors:  G D Ludwig; C G Kyle; M de Blanco
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965

9.  Inhibiton of alkaline phosphatase by beryllium and aluminum.

Authors:  C E Bamberger; J Botbol; R L Cabrini
Journal:  Arch Biochem Biophys       Date:  1968-01       Impact factor: 4.013

10.  Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism.

Authors:  R Ondreicka; E Ginter; J Kortus
Journal:  Br J Ind Med       Date:  1966-10
View more
  4 in total

1.  Aluminium levels in the blood plasma of persons working in the aluminium industry.

Authors:  C Schlatter; A Steinegger; U Rickenbacher; C Hans; A Lengyel
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  [The analyses of aluminum in serum and urine for monitoring of exposed persons (author's transl)].

Authors:  H Valentin; P Preusser; K H Schaller
Journal:  Int Arch Occup Environ Health       Date:  1976-10-21       Impact factor: 3.015

Review 3.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

4.  Aluminum in the environment and human health.

Authors:  J R Sorenson; I R Campbell; L B Tepper; R D Lingg
Journal:  Environ Health Perspect       Date:  1974-08       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.